Design and Synthesis of Cyclic Inhibitors of Matrix Metalloproteinases and TNF-α Production
- 1 May 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (11) , 1745-1748
- https://doi.org/10.1021/jm970849z
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Families of zinc metalloproteasesPublished by Wiley ,2001
- COMPARISON OF SNAKE VENOM REPROLYSIN AND MATRIX METALLOPROTEINASES AS MODELS OF TNF-α CONVERTING ENZYMEBioorganic & Medicinal Chemistry Letters, 1997
- Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivoBritish Journal of Pharmacology, 1997
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Meta-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease InhibitorsJournal of Medicinal Chemistry, 1997
- Review Oncologic, Endocrine & Metabolic: Recent developments in matrix metalloproteinase inhibitorsExpert Opinion on Therapeutic Patents, 1995
- Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitorNature, 1994
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingNature, 1994
- Matrix metalloproteinases and their inhibitors in connective tissue remodelingThe FASEB Journal, 1991